Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.600
+0.110 (4.42%)
Jul 24, 2026, 5:23 PM CET

STO:NEWBRY Balance Sheet

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Cash & Equivalents
14.6814.5615.38.5333.3313.15
Cash & Short-Term Investments
14.6814.5615.38.5333.3313.15
Cash Growth
25.76%-4.84%79.44%-74.42%153.58%-
Accounts Receivable
-----1.08
Other Receivables
25.3922.923.6816.61.371.25
Total Trade Receivables
25.3922.923.6816.61.372.33
Inventory
14.73952.111.77-
Other Current Assets
-----2.91
Total Current Assets
54.7946.4643.9727.2436.4715.77
Other Intangible Assets
29.7130.8946.945.6850.4323.09
Goodwill
-----3.95
Other Long-Term Assets
29.7130.8946.945.6850.43-
Total Assets
84.577.3590.8772.9286.9142.81
Accounts Payable
-----1.88
Accrued Expenses
-----2.23
Other Current Liabilities
-----0.23
Total Current Liabilities
54.5830.8529.4511.776.064.34
Other Long-Term Liabilities
3.653.759.5111.7712.08-
Total Long-Term Liabilities
3.653.759.5111.7712.08-
Total Liabilities
58.2334.638.9523.5418.144.34
Common Stock
-----0.16
Additional Paid-in Capital
-----43.89
Retained Earnings
------5.58
Total Common Shareholders' Equity
-----38.47
Shareholders' Equity
26.2742.7551.9249.3868.7738.47
Total Liabilities & Equity
84.577.3590.8772.9286.9142.81
Net Cash (Debt)
14.6814.5615.38.5333.3313.15
Net Cash Growth
25.76%-4.84%79.44%-74.42%153.58%-
Net Cash Per Share
0.440.470.620.431.700.84
Book Value
-000038.47
Book Value Per Share
-----2.45
Tangible Book Value
-29.71-30.89-46.9-45.68-50.4311.43
Tangible Book Value Per Share
-0.88-1.00-1.91-2.31-2.570.73